Treatment of bicalutamide-induced gynecomastia with breast-reduction surgery in prostate cancer

Journal of Clinical Oncology

Volumn 24, Issue 18, 2006, Pages 2958-2959

  Nakabayashi, Mari ^a   Bartlett, Richard A ^a   Oh, William K ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICALUTAMIDE; PROSTATE SPECIFIC ANTIGEN; ANILIDE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADULT; ARTICLE; BODY IMAGE; BREAST REDUCTION; BREAST SURGERY; CANCER RADIOTHERAPY; CASE REPORT; DRUG DOSE REGIMEN; GENDER IDENTITY; GYNECOMASTIA; HUMAN; MALE; MONOTHERAPY; PATIENT DECISION MAKING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROPHYLAXIS; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; PROSTATE TUMOR;

ANILIDES; ANTINEOPLASTIC AGENTS, HORMONAL; GYNECOMASTIA; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 33745516890     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.8505     Document Type: Article

References (8)

1. Rohrich RJ, Ha RY, Kenkel JM, Adams WP Jr: Classification and management of gynecomastia: Defining the role of ultrasound-assisted liposuction. Plast Reconstr Surg 111:909-923, discussion 924-925, 2003
2. Tyrrell CJ: Gynaecomastia: Aetiology and treatment options. Prostate Cancer Prostatic Dis 2:167-171, 1999
3. Wilson JD, Aiman J, MacDonald PC: The pathogenesis of gynecomastia. Adv Intern Med 25:1-32, 1980
4. Wirth MP, See WA, McLeod DG, et al: Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: Results from the second analysis of the early prostate cancer program at median followup of 5.4 years. J Urol 172:1865-1870, 2004
5. Iversen P, Johansson JE, Lodding P, et al: Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6. J Urol 172:1871-1876, 2004
6. Iversen P, Tyrrell CJ, Kaisary AV, et al: Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup. J Urol 164:1579-1582, 2000
7. Ofman US: Preservation of function in genitourinary cancers: Psychosexual and psychosocial issues. Cancer Invest 13:125-131, 1995
8. Prezioso D, Piccirillo G, Galasso R, et al: Gynecomastia due to hormone therapy for advanced prostate cancer: A report of ten surgically treated cases and a review of treatment options. Tumori 90:410-415, 2004